Skip to main content
Premium Trial:

Request an Annual Quote

Roche Hands HUPO 5M for Data Repository; 80M More Expected from Investors, NIH

SAN DIEGO, June 6 - Roche will give the Human Proteome Project 5 million, or roughly $4.7 million, to help create a public repository of antibodies, HUPO President Sam Hanash said today.

 

Hanash added that the pharma giant is putting together an international group of investors that will infuse an additional 40 million towards the enterprise. He said Roche expects the US National Institutes of Health to cough up matching funds. A timeline was not immediately available.

Hanash, who made the announcement at the Beyond Genome meeting here, said Roche's commitment came during a meeting in late April. (At press time, Roche had not confirmed the account.)

 

The HUPO head also said that Amersham Biosciences had agreed during that same April meeting to become the organization's first sponsor with a contribution of approximately $500,000.

 

Earlier this week, HUPO and Amersham kicked off a joint North American and European tour to spread the work about new proteomics research and educate researchers about new technologies in the field.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.